Larvol Delta - A-Study-to-Evaluate-the-Efficacy-and-Safety-of-CBL514-Injection-for-Reducing-Subcutaneous-Fat--SUPREME02-

CBL-514 - Caliway Biopharmaceuticals

http://clinicaltrials.gov/ct2/show/NCT07526974

Apr 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next